DeQuattro V, deGrau A, Foti A, Kim S J, DeQuattro E, Allen J
Am J Cardiol. 1985 Aug 30;56(6):39D-45D. doi: 10.1016/0002-9149(85)91114-2.
Blood pressure control in mild and moderate hypertension may reduce morbidity and mortality. On the other hand, antihypertensive drugs may cause adverse metabolic, electrolyte, neural and hemodynamic alterations that detract from their effectiveness. The effect of hydrochlorothiazide (HCTZ) on some of these factors was compared with that of HCTZ and a sympatholytic drug in 20 hypertensive patients with left ventricular hypertrophy and retinopathy. HCTZ controlled blood pressure at rest and during maximum treadmill exercise (-12 mm Hg systolic and diastolic pressure (p less than 0.05), reduced left ventricular mass by 7% (p less than 0.05) and lessened aerobic impairment at maximum treadmill exercise by 45% (p less than 0.05). These effects were further improved after "neural blockade." A potential adverse effect of HCTZ--hypokalemia (-0.6 mEq/liter, p less than 0.01)--and the associated incidence of ectopy during effort (50%) were lessened after neutralizing neural tone. Combination therapy with low-dose diuretic and sympatholytic drugs was effective and well tolerated in patients with cardiac and vascular sequelae of moderately severe hypertension.
轻度和中度高血压患者的血压控制可降低发病率和死亡率。另一方面,抗高血压药物可能会引起不良的代谢、电解质、神经和血流动力学改变,从而降低其疗效。在20例伴有左心室肥厚和视网膜病变的高血压患者中,比较了氢氯噻嗪(HCTZ)对其中一些因素的影响与HCTZ和一种抗交感神经药物联合使用的效果。HCTZ可控制静息血压和最大运动平板运动时的血压(收缩压和舒张压均降低12 mmHg,p<0.05),使左心室质量减少7%(p<0.05),并使最大运动平板运动时的有氧功能损害减轻45%(p<0.05)。“神经阻滞”后这些效果进一步改善。HCTZ的一个潜在不良反应——低钾血症(降低0.6 mEq/升,p<0.01)以及运动期间异位心律的相关发生率(50%)在消除神经张力后降低。低剂量利尿剂和抗交感神经药物联合治疗对中度严重高血压的心脏和血管后遗症患者有效且耐受性良好。